An interview with Damon Race, CEO of GeneVentive Therapeutics
Episode 89 · Jul 19, 2023, 08:14 PM
Share
Subscribe
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Damon Race, CEO of GeneVentive Therapeutics. The North Carolina-based startup hopes to develop a universal gene therapy that will benefit hemophilia A and B patients with inhibitors.